Appropriate Treatment of Ischemic Stroke That Is Essential for the Reduction of Mortality and Morbidity : Should We Use Hyperbaric Oxygen Therapy Together With Recombinant Tissue Plasminogen Activator for Improving Brain Oxygenation and Before Recombinant Tissue Plasminogen Activator to Minimize the Risk of Massive Bleeding?
| Errataetall: |
CommentOn: Crit Care Med. 2020 Nov;48(11):1654-1663. - PMID 32947473 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
|---|---|
| Enthalten in: |
Critical care medicine - 49(2021), 8 vom: 01. Aug., Seite e806-e807 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Honore, Patrick M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Comment |
|---|
| Anmerkungen: |
Date Completed 06.09.2021 Date Revised 06.09.2021 published: Print CommentOn: Crit Care Med. 2020 Nov;48(11):1654-1663. - PMID 32947473 Citation Status MEDLINE |
|---|
| doi: |
10.1097/CCM.0000000000004988 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328074837 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328074837 | ||
| 003 | DE-627 | ||
| 005 | 20231225202159.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/CCM.0000000000004988 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1093.xml |
| 035 | |a (DE-627)NLM328074837 | ||
| 035 | |a (NLM)34261938 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Honore, Patrick M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Appropriate Treatment of Ischemic Stroke That Is Essential for the Reduction of Mortality and Morbidity |b Should We Use Hyperbaric Oxygen Therapy Together With Recombinant Tissue Plasminogen Activator for Improving Brain Oxygenation and Before Recombinant Tissue Plasminogen Activator to Minimize the Risk of Massive Bleeding? |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.09.2021 | ||
| 500 | |a Date Revised 06.09.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Crit Care Med. 2020 Nov;48(11):1654-1663. - PMID 32947473 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Fibrinolytic Agents |2 NLM | |
| 650 | 7 | |a Tissue Plasminogen Activator |2 NLM | |
| 650 | 7 | |a EC 3.4.21.68 |2 NLM | |
| 700 | 1 | |a Redant, Sebastien |e verfasserin |4 aut | |
| 700 | 1 | |a Kaefer, Keitiane |e verfasserin |4 aut | |
| 700 | 1 | |a Barreto Gutierrez, Leonel |e verfasserin |4 aut | |
| 700 | 1 | |a Kugener, Luc |e verfasserin |4 aut | |
| 700 | 1 | |a Attou, Rachid |e verfasserin |4 aut | |
| 700 | 1 | |a Gallerani, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a De Bels, David |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Critical care medicine |d 1973 |g 49(2021), 8 vom: 01. Aug., Seite e806-e807 |w (DE-627)NLM000002631 |x 1530-0293 |7 nnns |
| 773 | 1 | 8 | |g volume:49 |g year:2021 |g number:8 |g day:01 |g month:08 |g pages:e806-e807 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/CCM.0000000000004988 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 49 |j 2021 |e 8 |b 01 |c 08 |h e806-e807 | ||